5th Circuit Affirms Dismissal Of Claims Against 5 Brand, Generic Drug Makers

(February 8, 2021, 12:58 PM EST) -- NEW ORLEANS — The Fifth Circuit U.S. Court of Appeals on Feb. 5 affirmed dismissal of a pro se drug liability case against five brand-name and generic pharmaceuticals companies, saying the...

To view the full article, register now.